BIOXQ
The computed 12-month bankruptcy probability of BIOXQ is 0.6% (low). The 2024 annual accounts show equity of €257k and a net result of €119k. Its solvency ranks better than 73% of 3372 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €257k |
| Net result | €119k |
| Better than sector | 73% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 72.6% | 55.1% | |
| Net result | €119k | €19k | |
| Equity | €257k | €45k | |
| Gross operating margin | €175k | €38k | |
| Total assets | €354k | €95k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €174k |
| Net profit | €119k |
| Cash flow | €138k |
| Staff costs | - |
| Income taxes | €34k |
| Dividends | - |
| Total assets | €354k |
| Equity | €257k |
| Debt | €97k |
| of which ≤ 1y | €97k |
| of which > 1y | - |
| Working capital | €226k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.34 |
| Quick ratio | 3.34 |
| Working capital ratio | 64.0% |
| Solvency | 72.6% |
| Debt / equity | 0.38 |
| Long-term debt ratio | - |
| Interest coverage | 83.27 |
| Gross margin | - |
| Net margin | - |
| ROA | 33.7% |
| ROE | 46.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €354k |
| Fixed assets | 21/28 | €31k |
| Tangible fixed assets | 22/27 | €31k |
| Current assets | 29/58 | €323k |
| Amounts receivable within one year | 40/41 | €31k |
| Investments | 50/53 | €262k |
| Cash & bank | 54/58 | €29k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €354k |
| Equity | 10/15 | €257k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €252k |
| Amounts payable | 17/49 | €97k |
| Amounts payable within one year | 42/48 | €97k |
| Trade debts payable within one year | 44 | €56k |
| Income statement | ||
| Gross operating margin | 9900 | €175k |
| Operating result | 9901 | €155k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €153k |
| Income taxes | 67/77 | €34k |
| Net result for the period | 9904 | €119k |
| Result to be appropriated | 9905 | €119k |
| NACE primary | Engineering activities(71121) |
| Legal form | Private limited company(610) |
| Incorporation | 17-08-2022 |
| Status | Active |
| Postal code | 3511 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71483E0296/00G000 | Flanders | 1,688 m² | 1 · 139 m² | 9.4 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BIOXQ |